Endoscopic submucosal dissection to remove large colorectal lesions was performed safely and successfully in an outpatient setting, based on data from more than 600 patients. The widespread adoption ...

Endoscopic submucosal dissection (ESD) appeared effective for removing superficial gastric neoplasia and is therefore a viable option for patients in North America, a retrospective, multicenter study ...

World’s First Fully Robotic Procedure by a Gastroenterologist Completed using EndoQuest’s Endoluminal Surgical System in the PARADIGM Trial Dr. Norio Fukami of Mayo Clinic, Arizona is first ...

Endoscopic submucosal dissection (ESD) represents a significant advance in therapeutic endoscopy with the major advantage being the ability to achieve a higher en bloc resection rate for early stage ...

Gastrointestinal neoplasms can be cured by local resection as long as the lesions are in the early stage and have not metastasized. Endoscopic resection is a minimally invasive treatment for ...

Olympus launched DualKnife J, an endoscopic submucosal dissection electrosurgical knife, May 31. The knife will be on display at Digestive Disease Week, June 2 to June 5 in Washington, D.C. Here’s ...

Additionally, the publication of clinical guidelines by leading gastroenterological societies in Western countries has legitimized the use of ESD for treating early-stage gastric, esophageal, and ...

The figure was derived from‘International consensus on the management of large (≥20 mm) non-pedunculated colorectal polyps: A World Endoscopy Organisation Delphi study’; Djinbachian et al, 2023; Under ...

A research team at Tohoku University, in collaboration with Denka Company Limited and U-A Corporation, has developed a ...

In a recent press release from Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today ...

Please provide your email address to receive an email when new articles are posted on . Bartel and colleagues assigned 3 mg budesonide orally twice a day for 8 weeks to 25 patients who underwent ...

The MarketWatch News Department was not involved in the creation of this content. CENTER VALLEY, Pa., May 22, 2025 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to ...